Ritholtz Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
10,508
-11,283
| -52% | -$189K | ﹤0.01% | 926 |
|
|
2025
Q1 | $335K | Sell |
21,791
-13,163
| -38% | -$202K | 0.01% | 714 |
|
|
2024
Q4 | $770K | Sell |
34,954
-6,689
| -16% | -$147K | 0.02% | 447 |
|
|
2024
Q3 | $750K | Buy |
41,643
+30,374
| +270% | +$547K | 0.02% | 444 |
|
|
2024
Q2 | $183K | Buy |
+11,269
| New | +$183K | 0.01% | 773 |
|
|
2022
Q4 | – | Sell |
-10,560
| Closed | -$85K | – | 727 |
|
|
2022
Q3 | $85K | Buy |
+10,560
| New | +$85K | ﹤0.01% | 691 |
|
|
2018
Q2 | – | Sell |
-10,035
| Closed | -$171K | – | 120 |
|
|
2018
Q1 | $171K | Sell |
10,035
-1,915
| -16% | -$32.6K | 0.05% | 114 |
|
|
2017
Q4 | $226K | Buy |
+11,950
| New | +$226K | 0.07% | 105 |
|